GLP1 has already been described as an anti-apoptotic factor in a few cardiac disease models in vitro (Ravassa et al. 2011, Noyan-Ashraf et al. 2013) and in vivo (Bose et al. 2005, Timmers et al. 2009). Here, GLP1R is linked to heart disorder.